Skip to main content
. Author manuscript; available in PMC: 2010 Aug 16.
Published in final edited form as: Genes Chromosomes Cancer. 2010 Apr;49(4):342–352. doi: 10.1002/gcc.20746

TABLE 3.

PTPRD Mutations in Lung Cancer

Sample Histological type No. of exon (nucleotide change) Predicted effect mRNA levela
Cell line
  Ma29 ADC 11 (C1184T: Homo) Ala395Val   0.0015
  H23 ADC 11 (C1201T: Homo) Arg401Trp   0.053
  Sq-5 SQC 20 (C3299T: Hetero) Thr1100Met   0.00068
  H1155 LCC 14 (C2057T: Hetero) Thr686Ile   0.035
  PC13 LCC 20 (A3164G: Hetero) Asp1055Gly   0.010
  Lu65 LCC 32 (G5258T: Homo) Gly1753Cys   0.00047
  H2171b SCC 5 (G460T: Homo) Asp154Tyr   0.025
  H526 SCC 17 (A2443G: Hetero) Lys815Glu   0.70
Surgical specimen
  Na68Tb SQC 4 (G235T: Hetero) Gly79STOP   0.10
  Na182Tb SQC 21 (TG3472–3473AT: Hetero) Trp1158Met   0.27
  S171Tb SCC 15 (G2206T: Hetero) Val1736Leu Not tested
  1662Tb SCC 17 (C IVS17+16 T: Hetero) Unknown Not tested
a

Relative expression level to noncancerous lung tissues.

b

Validated to be somatic mutation.